Fact Sheet: Chloramine-T INAD 9321

for detailed information, see INAD study protocol, use link on the left
last updated: 1 December 2011

The following links are specific to:

Drug summary & history

List of FDA-Approved drugs

Drug forms to be completed

Examples of completed forms

INAD study protocol

Material Safety Data Sheet

Study Summaries

What's the status of this drug's

Print this drug fact sheet

Print all drug fact sheets

Sign-up via the INAD Program Management System (IPMS)

Information on EPA's National Pollutant Discharge Elimination System (NPDES) Permits

Authorization & Categorical Exclusion Letters

Objective/purpose: Collect supportive and pivotal data needed to establish the effectiveness of chloramine-T to control mortality caused by certain bacterial diseases.
Drug name: Chloramine-T (Halamid®) Chloramine-T (Actamide)
Source of drug:

Western Chemical Inc.

B.L. Mitchell, Inc.
Address: 1269 Lattimore Road
Ferndale, WA 98248 USA
1774 E Azalea Dr.
Greenville, MS 38701-7505
Contact: Jason Montgomery
Toll Free: 800-283-5292 ext 4175
email: jasonm@wchemical.com
webpage: http://www.wchemical.com/

Martin Mitchell
Phone: 662-686-9002
Fax: 662-686-9020
email: biologist@tecinfo.com
webpage: http://www.blmitchell.com/
Target pathogen(s): External flavobacteriosis (e.g., bacteria responsible for bacterial gill disease and external columnaris)
Method of administration: Immersion: flow-through or standing-bath treatment
Treatment dosage:

10, 15 or 20 mg/L for BGD and external columnaris in cold, cool and warmwater fish.

Treatment regimen:

60 minutes per day for up to 3 days.

Withdrawal period:

None. Fish may be released or harvested for market immediately following treatment.

Required test parameters: Investigator must collect mortality data throughout the 5-day pre-treatment, treatment, and 14-day post-treatment periods. Investigator should also report general fish behavior and any adverse effects relating to treatment.
Limitations or restrictions on use:

Not for use on fish in culture systems with no outflows .

Investigator must follow all instructions in the Study Protocol for INAD 9321 regarding drug acquisition and handling, fish treatment and disposition, and data reporting requirements.

Required INAD fee: $400.00 per facility per year
AADAP contact for other information: Ms. Bonnie Johnson, FWS - AADAP
Phone: 406-994-9905
Fax: 406-582-0242

Disclaimer: Product and company names mentioned in this website, or mentioned in materials accessed via this website, are for informational purposes only. The mention of such does not imply endorsement by the Aquatic Animal Drug Approval Partnership, the U.S. Fish & Wildlife Service or any other organization of the U.S. Government.